In one of the comments AMBS was mentioned as being further along than a lot of the tests mentioned. Someone then refuted how far along we are. His "evidence" is that the only people talking about it is AMBS so therefore, it's not a good test.

Everything else aside, I'm only bringing this up because he struck a nerve. I do see conference's where we're marketing to biotech companies, but he is right in that I don't see much marketing to "Investors". Doesn't AMBS have an investor's relationship department?

I don't believe in "If you build it, they will come". I believe in "If you build it, then tell everyone what you built, they will come". Are we telling everyone?